The inhibitory effect of tranilast on cell proliferation, as indicated by the reduced number of Ki67 positive cells coupled with increased apoptosis, as indicated by the increased number of cells staining for cleaved caspase 3 and inhibition of CCND1 and E2F1, indicates that tranilast is also effective in inhibiting tumor growth and progression. This evidence concerns the gene E2F1 and neoplasm.